PRECLINICAL STUDIES

Investigational New Drugs

, Volume 28, Issue 6, pp 766-782

First online:

Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells

  • Pay-Chin LeowAffiliated withDepartment of Pharmacy, Faculty of Science, National University of Singapore
  • , Quan TianAffiliated withDepartment of Pharmacy, Faculty of Science, National University of Singapore
  • , Zhan-Yuin OngAffiliated withDepartment of Pharmacy, Faculty of Science, National University of Singapore
  • , Zheng YangAffiliated withDepartment of Orthopedic Surgery, Yong Loo Lin School of Medicine, National University of SingaporeDepartment of Oral Maxillo-Facial Surgery, Faculty of Dentistry, National University of Singapore
  • , Pui-Lai Rachel EeAffiliated withDepartment of Pharmacy, Faculty of Science, National University of Singapore Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Summary

Aberrant activation of the Wnt/β-catenin signaling pathway promotes osteosarcoma tumorigenesis and metastasis. In this study, we tested the hypothesis that osteosarcoma progression may be delayed by disrupting the Wnt/β-catenin pathway using small molecule inhibitors such as curcumin and PKF118-310. Effective inhibitions of the Wnt/β-catenin pathway by curcumin and PKF118-310 in osteosarcoma cells were shown by the suppression of both intrinsic and activated β-catenin/Tcf transcriptional activities using luciferase reporter assays. Western blot analysis revealed that there was no change in the amount of cytosolic β-catenin, although nuclear β-catenin was markedly reduced by treatment with either compounds. We next performed wound healing and Matrigel invasion assays and observed a dose-dependent decrease in osteosarcoma cell migration and invasion with curcumin and PKF118-310 treatment. Overexpression of the wild-type β-catenin plasmid in osteosarcoma cells resulted in enhanced cell invasiveness but this effect was significantly overcome by curcumin. Gelatin zymography and Western blotting showed that reduced cell invasion with curcumin and PKF118-310 treatment correlated with the activity and protein level of matrix metalloproteinase-9 under conditions of intrinsic or extrinsic Wnt/β-catenin activation. Using cell apoptosis assay and cell cycle analysis, we further showed that the anti-proliferative effect of PKF118-310 is attributed to PKF118-310-induced apoptosis and G2/M phase arrest. Lastly, we observed that these anti-cancer effects correlated with the decreased expression of cyclin D1, c-Myc and survivin. Our findings strongly suggest that curcumin and PKF118-310 have great therapeutic potential for the treatment of osteosarcoma.

Keywords

PKF118-310 Curcumin Osteosarcoma Wnt signaling Proliferation Invasion